Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Eris Lifesciences Ltd ( (IN:ERIS) ).
Eris Lifesciences Ltd has announced a scheduled meeting with Mirae Asset Mutual Fund on March 24, 2025, as part of its ongoing engagement with institutional investors and analysts. The meeting, which will be conducted in-person, aims to discuss publicly available information without disclosing any unpublished price-sensitive information, reflecting the company’s commitment to transparency and regulatory compliance.
More about Eris Lifesciences Ltd
Eris Lifesciences Ltd operates in the pharmaceutical industry, focusing on the development and marketing of branded pharmaceutical products. The company primarily serves the Indian market, offering a range of therapeutic products across various medical specialties.
YTD Price Performance: -2.59%
Average Trading Volume: 5,171
Current Market Cap: 175.6B INR
Find detailed analytics on ERIS stock on TipRanks’ Stock Analysis page.